Molycorp (MCP) Tanks on Production Problems, Share Buyback

Michael Teague |

Shares for industrial metals and mineral producer Molycorp Inc. (MCP) had capitulated halfway through Tuesday trading after the company announced that its cash flow for the first 9 months of 2013 had fallen short of expectations.

Cash flow has not been Molycorp’s only problem of late, however. Production at the company’s rare-earth oxide mine in California has only sporadically managed an annualized output rate of 15,000 metric tons, while capacity had been projected at a rate of nearly 20,000.



The cash flow problem may not be as important as what is going on at the company’s Mountain Pass mine/production facility, however. Rare earth metals are the unheralded new resource that various world powers are quietly coveting for the time being. Their worth is derived from the fact that they are used in a wide variety of industries, including medicine, defense and technology, particularly in cell phones and other mobile devices.

Unfortunately for Molycorp, the cerium being extracted from the Mountain Pass mine is of much lower quality than had been expected. Just under 50 percent of what the mine produces is actually cerium, which is currently one of the 17 rare earths with the lowest demand.

Furthermore, the company’s projections for 2014 are based on some very tenuous assumptions, in particular one that shows the company able to sell a significant portion of its cerium stockpile, which is by no means a given.

The final result was that the company also announced a stock buyback worth some $200 million, a sign that so far has been interpreted by investors as an indication of a desperate, distressed company. Shares for Molycorp were down nearly 20 percent to $5.70 a piece heading towards the closing bell.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
HNCMF Hutchison China Meditech 32.74 0.00 0.00 0

Comments

Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…

D-Wave

D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…